Chain for claim_ef38bd394801435c
8 nodes. Root first; inputs below.
depth 0 · claim · via classify
claim_ef38bd394801435c
**Selected angle:** `source` ## One-sentence thesis The cited direct receipts support a bounded working claim: semaglutide (1.8%) versus placebo (2.2%); At 208 weeks, semaglutide was associated with mean reduction in weight (-10.2%) versus placebo (-1.5%; P < 0.0001). **Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived clai…
sha256 4ec7e520c621fabd…
depth 1 · source
source_2d692921e52e4313
**Selected angle:** `source` ## One-sentence thesis The cited direct receipts support a bounded working claim: semaglutide (1.8%) versus placebo (2.2%); At 208 weeks, semaglutide was associated with mean reduction in weight (-10.2%) versus placebo (-1.5%; P < 0.0001). **Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived cla…
sha256 308b183070a23e53…
depth 1 · source
source_db90b882083d4ba6
{"publication_id": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "traces": [{"candidate_sources": [{"doi": "10.1038/s41591-024-03015-5", "study": "Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial", "url": null}, {"doi": "10.1038/s41591-024-02996-7", "study": "Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial", "…
sha256 d4da648a365e7cbf…
depth 1 · source
source_898ecac2cb164328
{"content_hash": null, "edges": [{"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_1", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_2", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_3", "type": "contains_claim"}, {"from": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "to": "claim_4", "type": "contains_clai…
sha256 a33ac9d80760277b…
depth 1 · source
source_0552cd02b0c14fcb
{"contradictions": ["_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty f…
sha256 add0535b25d5eaa8…
depth 1 · source
source_a31fb6d38d6f4328
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial,not…
sha256 294e49c28fed1518…
depth 1 · source
source_84dafe9842134b72
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "767dd1a7-1300-4f73-8821-ca5a468dbafd", "sources": [{"directness": "primary", "doi": "10.1038/s41591-024-03015-5", "risk_of_bias": "not appraised in public sidecar", "study": "Long-term kidney outcomes of semaglutide in obesity and cardio…
sha256 dad41bda45d7fa88…
depth 1 · source
source_14b0537b0b41476b
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 71886f3b1900c02c…